Arvinder Dhalla
Corporate Officer/Principal bei RANI THERAPEUTICS HOLDINGS, INC.
Profil
Arvinder Dhalla is currently working as the Vice President of Clinical Operations at Rani Therapeutics LLC and as the Vice President of Clinical Development at Rani Therapeutics Holdings, Inc. Previously, she worked as the Biology Director of Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Dr. Dhalla holds a doctorate degree from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Aktive Positionen von Arvinder Dhalla
| Unternehmen | Position | Beginn |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | - |
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Arvinder Dhalla
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Arvinder Dhalla
| Panjab University Chandigarh | Graduate Degree |
| University of Manitoba | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
